Title : Sacubitril/Valsartan: Neprilysin Inhibition 5 Years After PARADIGM-HF.

Pub. Date : 2020 Oct

PMID : 33004114






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Sacubitril/valsartan, an angiotensin receptor-neprilysin inhibitor (ARNI), has been shown to reduce the risk of cardiovascular death or heart failure hospitalization and improve symptoms among patients with chronic heart failure with reduced ejection fraction compared to enalapril, the gold standard angiotensin-converting enzyme inhibitor. Valsartan angiotensin I converting enzyme Homo sapiens